Contact
searchSearch
HMP Global

November 2015 - FRMC

Department

Conference Insider
AMCP: Qualified Health Plans: Ratings, Restrictions, and Requirements for 2016 and Beyond
12/21/2015
Alessia D'Anna
CMS submitted its letter outlining the 2016 prescription drug requirements to insurers in the federally facilitated marketplace.
CMS submitted its letter outlining the 2016 prescription drug requirements to insurers in the federally facilitated marketplace.
CMS submitted its letter...
12/21/2015
First Report Managed Care
Conference Insider
PCMH: Systematizing Patient-Centered Medical Home Transformation
12/16/2015
Systematizing Patient-Centered Medical Home Transformation With the rise of patient-centered medical homes (PCMHs) and accountable care organizations (ACOs), it is important for managed care professionals to understand how these models can...
Systematizing Patient-Centered Medical Home Transformation With the rise of patient-centered medical homes (PCMHs) and accountable care organizations (ACOs), it is important for managed care professionals to understand how these models can...
Systematizing Patient-Centered...
12/16/2015
First Report Managed Care
Conference Insider
ECTRIMS: Impact of Impaired Walking On Health Care Utilization
12/16/2015
Impaired mobility and walking in patients with multiple sclerosis (MS) negatively impacts all aspects of the patients’ lives.
Impaired mobility and walking in patients with multiple sclerosis (MS) negatively impacts all aspects of the patients’ lives.
Impaired mobility and walking in...
12/16/2015
First Report Managed Care
Conference Insider
ECTRIMS: EMERALD Shows High Compliance Rate With Alemtuzumab
12/16/2015
Interim analysis from the ongoing EMERALD [Evaluation of the Management of Infusion Reactions in Alemtuzumab- treated Patients] study will help provide additional guidance for optimizing the management of infusion-associated reactions (IARs)...
Interim analysis from the ongoing EMERALD [Evaluation of the Management of Infusion Reactions in Alemtuzumab- treated Patients] study will help provide additional guidance for optimizing the management of infusion-associated reactions (IARs)...
Interim analysis from the...
12/16/2015
First Report Managed Care
Conference Insider
ECTRIMS: Overcoming Uncertainty When Managing MS Relapse
12/16/2015
Relapses are one of the dis­tinctive features of relapsing-remitting multiple sclerosis (MS) and serve as the defining clinical presentation that leads to diagnosis and delivery of value-based care. There is uncertainty and het­erogeneity in...
Relapses are one of the dis­tinctive features of relapsing-remitting multiple sclerosis (MS) and serve as the defining clinical presentation that leads to diagnosis and delivery of value-based care. There is uncertainty and het­erogeneity in...
Relapses are one of the...
12/16/2015
First Report Managed Care
Literature Review: Hyperkalemia
12/18/2015
  New Treatment for Hyperkalemia Current therapy options are limited and there is an increased risk of drug–drug interactions when patients take >1 potassium increasing drug. Hyperkalemia is defined as elevated serum potassium...
  New Treatment for Hyperkalemia Current therapy options are limited and there is an increased risk of drug–drug interactions when patients take >1 potassium increasing drug. Hyperkalemia is defined as elevated serum potassium...
  New Treatment for...
12/18/2015
First Report Managed Care
MANAGING ASTHMA: Keys to Delivering Value-Based Care
12/16/2015
Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
Asthma can be difficult to...
12/16/2015
First Report Managed Care
Department
Disease State Overview: MANAGING ASTHMA: Keys to Delivering Value-Based Care
12/16/2015
MANAGING ASTHMA: Keys to Delivering Value-Based Care Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
MANAGING ASTHMA: Keys to Delivering Value-Based Care Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
MANAGING ASTHMA: Keys to...
12/16/2015
First Report Managed Care
Department
Literature Review: Psoriasis Carries Hefty Price Tag
12/16/2015
Costs associated with psoriasis may be viewed from several different perspectives, including the patient, payer, and society.  
Costs associated with psoriasis may be viewed from several different perspectives, including the patient, payer, and society.  
Costs associated with psoriasis...
12/16/2015
First Report Managed Care
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost
12/16/2015
Stephanie Vaccaro
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost​ Antibiotic resistance is exacting a high price in the US. In April 2011, the Centers for Dis­ease Control (CDC) reported that antibiotic resistance accounted for...
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost​ Antibiotic resistance is exacting a high price in the US. In April 2011, the Centers for Dis­ease Control (CDC) reported that antibiotic resistance accounted for...
Burden of Antibiotic Resistance:...
12/16/2015
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Improving Health Outcomes Through Early COPD and Asthma Intervention
10/04/2024
Hannah Musick
Research published in the New England Journal of Medicine shows that early diagnosis and treatment of undiagnosed COPD or asthma can reduce health care utilization for respiratory illness and improve overall health outcomes.
Research published in the New England Journal of Medicine shows that early diagnosis and treatment of undiagnosed COPD or asthma can reduce health care utilization for respiratory illness and improve overall health outcomes.
Research published in the New...
10/04/2024
First Report Managed Care
News
Advances in Factor IX Therapy Offer New Hope for Hemophilia B Treatment
10/23/2024
Lisa Kuhns, PhD, MD
New factor IX therapies promise improved treatment for hemophilia B.
New factor IX therapies promise improved treatment for hemophilia B.
New factor IX therapies promise...
10/23/2024
First Report Managed Care
News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
Jolynn Tumolo
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
Risk of Psychiatric Comorbidity Higher in Patients With Ankylosing Spondylitis
05/19/2023
Jolynn Tumolo
Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.
Findings from a population-based, cross-sectional study suggest that patients with ankylosing spondylitis are at a higher risk of developing psychiatric disorders.
Findings from a...
05/19/2023
First Report Managed Care
Conference Coverage
Significant Number of Solid Tumor Drug Approvals Added Complexity to Existing Regimens
06/08/2023
Maria Asimopoulos
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug approvals for nonhematologic solid cancers in the last 12 years were for indications which added to existing regimens, which could increase costs and exposure to side effects, researchers said.
A significant portion of drug...
06/08/2023
First Report Managed Care

December 2015 Volume 12 Issue 11

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use